AzTrials
AzTrials

Vertebral FractureNCT05071625

CT Guided Percutaneous Vertebroplasty for Vertebral Non-union Following Posterior Fixation

An observational study of Vertebral Fracture and Vertebral Trauma, run by Centre Hospitalier Universitaire de Nice at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Traumatic thoracolumbar vertebral fractures are frequently treated with posterior fixation (PF) and vertebral augmentation, but sometimes vertebral augmentation is not performed, being judged too risky under fluoroscopic guidance alone. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Vertebral Fracture, Vertebral Trauma
What is being tested?
percutaneous vertebroplasty
Type of treatment
Surgery or procedure
How many people
10 participants
Where
1 siteFrance
Study dates
31 Mar 2019to 15 Sep 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: All patients treated with a percutaneous vertebroplasty in our centre between 01/07/2015 and 01/07/2020 under combined CT/fluoroscopy guidance

Who may be able to join

  • PVP performed between July 2015-July 2020 under combined CT and fluoroscopy guidance;
  • Previous PF for traumatic non-neurological thoracolumbar vertebral fracture;
  • Imaging evidence of vertebral non-union;
  • Pain and functional impairment persisting for more at least one month after PF;
  • Informed patient consent for PVP procedure under CT and fluoroscopy guidance;
  • Previous multidisciplinary case discussion between spine surgeons and interventional radiologists.

Who cannot join

  • Age inferior to 18 years old
  • Absence of complications due to orthopaedic hardware;

Trial locations and contacts

1 site in 1 country.

France1 site
  • CHU de NICE

    Nice, 06200

Other trials in France

About this study

Official title: A Retrospectice Evaluation of the Feasibility and Usefulness of a Percutaneous Vertebroplasty Performed on Patients Treated With Posterior Fixation Suffering Non-union After a Traumatic Non-neurologic Vertebral Fracture

Traumatic thoracolumbar vertebral fractures are frequently treated with posterior fixation (PF) and vertebral augmentation, but sometimes vertebral augmentation is not performed, being judged too risky under fluoroscopic guidance alone. An adjuvant CT/fluoroscopy guided percutaneous vertebroplasty (PVP) could be an option.

The aim was to evaluate feasibility, safety and effectiveness of PVP in patients with vertebral non-union (VNU) following PF performed without concomitant vertebral augmentation.

All patients treated in our institution with PVP between July 2015-July 2020 were retrospectively reviewed. Patients treated with CT/fluoroscopy guided PVP under local anesthesia for symptomatic VNU following PF were selected. Three criteria were established to assess cement distribution, considering vertebral filling of: 1)fracture cleft, 2)anterior two-thirds of the vertebral body, 3)from superior to inferior endplates. Numeric pain rating scale (NPRS) assessing grade of discomfort (0=no pain; 10=worst pain) and complications were evaluated before and one month after PVP.

Being tested
percutaneous vertebroplasty
Medical subject headings
Spinal Fractures

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • percutaneous vertebroplastyProcedure or surgery

    percutaneous vertebroplasty under combined CT/fluoroscopy guidance for non-union after posterior fixation performed for a traumatic non-neurologic thoraco-lumbar vertebral fracture.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Effectiveness of the procedure assessing consolidation and pain reduction 1 month after percutaneous vertebroplasty

    Numeric Pain Rate Scale (from 0 to 10 points, where 0 no pain, 10 maximum pain)

    Measured: 18 months

Secondary outcomes (2)
  1. Technical success of the percutaneous vertebroplasty

    criteria of cement filling rate of vertebral body established by the authors

    Measured: 18 months

  2. Safety of the procedure

    Complication rate during and after the procedure using CIRSE adverse event reports

    Measured: 18 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Oct 2021
  2. Study start31 Mar 2019
  3. Primary completion1 Jul 2020
  4. Study completion15 Sep 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
10 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05071625
Sponsor's protocol ID
21Imagerie02
Status last verified
Sep 2021
First submitted
28 Sep 2021
Last updated
8 Oct 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: no data sharing plan has been established

Questions about this trial

What is this clinical trial studying?

An observational study of Vertebral Fracture and Vertebral Trauma, run by Centre Hospitalier Universitaire de Nice at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Oct 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Effectiveness of the procedure assessing consolidation and pain reduction 1 month after percutaneous vertebroplasty (time frame: 18 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Oct 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT05071625 | AzTrials